HSIC - Henry Schein, Inc.
NASDAQ
->
Healthcare
->
Medical Distribution
Melville,
United States
Type: Equity
HSIC price evolution
HSIC
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $171 | $166 | $137 | $126 |
| Short term investments | ||||
| Net receivables | $1863 | $1573 | $1468 | $1470 |
| Inventory | $1815 | $1833 | $1843 | $1918 |
| Total current assets | $4488 | $4113 | $3911 | $3952 |
| Long term investments | $471 | $471 | $493 | $479 |
| Property, plant & equipment | $823 | $797 | $729 | $676 |
| Goodwill & intangible assets | $4791 | $4429 | $4013 | $3465 |
| Total noncurrent assets | $6085 | $5697 | $5235 | $4620 |
| Total investments | $471 | $471 | $493 | $479 |
| Total assets | $10573 | $9810 | $9146 | $8572 |
| Current liabilities | ||||
| Accounts payable | $1020 | $953 | $817 | $855 |
| Deferred revenue | ||||
| Short long term debt | $494 | $158 | $465 | $364 |
| Total current liabilities | $2683 | $2093 | $2276 | $2172 |
| Long term debt | $2247 | $2129 | $1417 | $1295 |
| Total noncurrent liabilities | $2737 | $2616 | $1864 | $1703 |
| Total debt | $2741 | $2287 | $1882 | $1659 |
| Total liabilities | $5420 | $4709 | $4140 | $3875 |
| Shareholders' equity | ||||
| Retained earnings | $3860 | $3897 | $3769 | $3684 |
| Other shareholder equity | -$206 | -$247 | -$210 | -$213 |
| Total shareholder equity | $3655 | $3651 | $3560 | $3472 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $171 | $117 | $117.97 | $421.19 |
| Short term investments | ||||
| Net receivables | $1863 | $1442 | $1451.83 | $1424.79 |
| Inventory | $1815 | $1963 | $1861.14 | $1512.5 |
| Total current assets | $4488 | $3988 | $3844.03 | $3791.41 |
| Long term investments | $471 | $472 | $423.87 | $366.44 |
| Property, plant & equipment | $823 | $667 | $691.41 | $630.85 |
| Goodwill & intangible assets | $4791 | $3480 | $3521.78 | $2983.82 |
| Total noncurrent assets | $6085 | $4619 | $4637.06 | $3981.12 |
| Total investments | $471 | $472 | $423.87 | $366.44 |
| Total assets | $10573 | $8607 | $8481.09 | $7772.53 |
| Current liabilities | ||||
| Accounts payable | $1020 | $1004 | $1053.93 | $1005.65 |
| Deferred revenue | ||||
| Short long term debt | $494 | $182 | $137.56 | $247.92 |
| Total current liabilities | $2683 | $2224 | $2306.51 | $2283.1 |
| Long term debt | $2247 | $1040 | $1079.12 | $754.5 |
| Total noncurrent liabilities | $2737 | $1712 | $1498.07 | $1177.35 |
| Total debt | $2741 | $1497 | $1216.68 | $1002.42 |
| Total liabilities | $5420 | $5161 | $3804.59 | $3460.45 |
| Shareholders' equity | ||||
| Retained earnings | $3860 | $3678 | $3595.23 | $3454.83 |
| Other shareholder equity | -$206 | -$233 | -$171.48 | -$108.08 |
| Total shareholder equity | $3655 | $3446 | $3425.13 | $3348.17 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3017 | $3100 | $3060 | |
| Cost of revenue | $2092 | $2125 | $2094 | |
| Gross Profit | $925 | $975 | $966 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $807 | $707 | $717 | |
| Total operating expenses | $886 | $774 | $791 | |
| Operating income | $39 | $201 | $175 | |
| Income from continuing operations | ||||
| EBIT | $48 | $200 | $174 | |
| Income tax expense | $1 | $41 | $39 | |
| Interest expense | $29 | $19 | $14 | |
| Net income | ||||
| Net income | $18 | $140 | $121 | |
| Income (for common shares) | $18 | $140 | $121 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $12339 | $12647 | $12401.02 | $10119.14 |
| Cost of revenue | $8478 | $8816 | $8728.77 | $7304.8 |
| Gross Profit | $3861 | $3831 | $3672.25 | $2814.34 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2956 | $2771 | $2812.66 | $2246.95 |
| Total operating expenses | $3246 | $3084 | $2820.59 | $2279.04 |
| Operating income | $615 | $747 | $851.66 | $535.3 |
| Income from continuing operations | ||||
| EBIT | $623 | $752 | $856.18 | $540.54 |
| Income tax expense | $120 | $170 | $197.35 | $95.37 |
| Interest expense | $87 | $44 | $27.6 | $41.38 |
| Net income | ||||
| Net income | $416 | $538 | $631.23 | $403.79 |
| Income (for common shares) | $416 | $538 | $631.23 | $403.79 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $18 | $137 | $140 | $121 |
| Operating activities | ||||
| Depreciation | $68 | $69 | $59 | $52 |
| Business acquisitions & disposals | -$285 | -$416 | -$249 | $1 |
| Stock-based compensation | $1 | $14 | $14 | $10 |
| Total cash flows from operations | -$32 | $231 | $274 | $27 |
| Investing activities | ||||
| Capital expenditures | -$79 | -$40 | -$37 | -$31 |
| Investments | $22 | |||
| Total cash flows from investing | -$327 | -$468 | -$301 | -$39 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$50 | -$50 | -$50 | -$99 |
| Net borrowings | $450 | $340 | $98 | $162 |
| Total cash flows from financing | $394 | $248 | $38 | $21 |
| Effect of exchange rate | -$30 | $18 | ||
| Change in cash and equivalents | $5 | $29 | $11 | $9 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $416 | $538 | $631.23 | $403.79 |
| Operating activities | ||||
| Depreciation | $248 | $212 | $209.53 | $185.54 |
| Business acquisitions & disposals | -$949 | -$147 | -$574.65 | -$60.17 |
| Stock-based compensation | $39 | $54 | $78.42 | $8.79 |
| Total cash flows from operations | $500 | $602 | $709.58 | $598.91 |
| Investing activities | ||||
| Capital expenditures | -$187 | -$96 | -$79.02 | -$48.83 |
| Investments | $22 | $9.76 | $12.78 | |
| Total cash flows from investing | -$1135 | -$276 | -$677.22 | -$115.02 |
| Financing activities | ||||
| Dividends paid | -$7.89 | |||
| Sale and purchase of stock | -$249 | -$483 | -$401.21 | -$73.79 |
| Net borrowings | $1050 | $259 | $161.43 | -$68.99 |
| Total cash flows from financing | $701 | -$315 | -$332.96 | -$187.19 |
| Effect of exchange rate | -$12 | -$12 | -$2.63 | $18.38 |
| Change in cash and equivalents | $54 | -$1 | -$303.22 | $315.09 |
News
Fundamentals
| Market cap | $9.07B |
|---|---|
| Enterprise value | $11.64B |
| Shares outstanding | 129.25M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | -10.50% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 2.35 |
| Book/Share | 29.87 |
| Cash/Share | 1.32 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.48 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.67 |
| Quick ratio | 1.00 |